Revenue: As of FY2025 Q4, the actual value is USD 49.22 M, missing the estimate of USD 50.62 M.EPS: As of FY2025 Q4, the actual value is USD 0.EBIT: As of FY2025 Q4, the actual value is USD -8.894 M.<h3>Financial Highlights - Fourth Quarter 2025 (Q4 2025) vs. Fourth Quarter 2024 (Q4 2024)</h3><h4>Revenue</h4><ul><li>Total Net Revenue: Decreased to $49.2 million in Q4 2025 from $62.3 million in Q4 2024, representing a 21% decline .<ul><li>U.S. Product Revenue, net: $41.1 million in Q4 2025 vs. $44.2 million in Q4 2024, a -7% change .</li><li>Europe Product Revenue, net: $2.3 million in Q4 2025 vs. $4.0 million in Q4 2024, a -42% change .</li><li>Rest-of-World (ROW) Product Revenue, net: $3.1 million in Q4 2025 vs. $11.9 million in Q4 2024, a -74% change .</li><li>Total Product Revenue, net: $46.5 million in Q4 2025 vs. $60.1 million in Q4 2024, a -23% change .</li><li>Licensing &amp; Royalties: Increased to $2.7 million in Q4 2025 from $2.2 million in Q4 2024, a 20% increase .</li></ul></li></ul><h4>Operational Metrics</h4><ul><li>Operating Expenses: Decreased to $29.5 million in Q4 2025 from $43.0 million in Q4 2024, a -31% change . Excluding a $4.1 million restructuring charge, Q4 2025 operating expenses were $25.4 million, a 41% decline .<ul><li>Cost of Goods Sold (COGS): Decreased to $26.1 million in Q4 2025 from $71.9 million in Q4 2024, a -64% change . Q4 2024 COGS included a one-time inventory restructuring charge of $36.5 million . Excluding one-time charges, Q4 2025 COGS decreased $2.8 million, or 10% .</li><li>Selling, General &amp; Administrative (SG&amp;A): Decreased to $20.1 million in Q4 2025 from $37.0 million in Q4 2024, a -46% change .</li><li>Research &amp; Development (R&amp;D): $5.4 million in Q4 2025 vs. $6.0 million in Q4 2024, a -10% change .</li><li>Restructuring: $4.1 million in Q4 2025 vs. $0 in Q4 2024 .</li></ul></li><li>Operating Loss: Narrowed significantly to -$6.3 million in Q4 2025 from -$52.5 million in Q4 2024, an 88% improvement .</li><li>Operating Margin %: Improved to -13% in Q4 2025 from -84% in Q4 2024 .</li><li>Net Loss: Improved to -$1.2 million in Q4 2025 from -$48.6 million in Q4 2024, a 97% improvement .</li><li>Net Margin: Improved to -2% in Q4 2025 from -78% in Q4 2024 .</li></ul><h3>Financial Highlights - Full Year 2025 (FY 2025) vs. Full Year 2024 (FY 2024)</h3><h4>Revenue</h4><ul><li>Total Revenue, net: $213,646 thousand in FY 2025 vs. $228,614 thousand in FY 2024 .<ul><li>Product revenue, net: $182,753 thousand in FY 2025 vs. $204,590 thousand in FY 2024 .</li><li>Licensing and royalty revenue: $30,893 thousand in FY 2025 vs. $24,024 thousand in FY 2024 .</li></ul></li></ul><h4>Operational Metrics</h4><ul><li>Cost of goods sold: $92,778 thousand in FY 2025 vs. $110,758 thousand in FY 2024 .</li><li>Cost of goods sold - restructuring inventory: $0 in FY 2025 vs. $36,474 thousand in FY 2024 .</li><li>Gross margin: $120,868 thousand in FY 2025 vs. $81,382 thousand in FY 2024 .</li><li>Total operating expenses: $171,038 thousand in FY 2025 vs. $173,179 thousand in FY 2024 .<ul><li>Selling, general and administrative: $115,003 thousand in FY 2025 vs. $152,310 thousand in FY 2024 .</li><li>Research and development: $19,806 thousand in FY 2025 vs. $20,869 thousand in FY 2024 .</li><li>Restructuring: $36,229 thousand in FY 2025 vs. $0 in FY 2024 .</li></ul></li><li>Operating loss: -$50,170 thousand in FY 2025 vs. -$91,797 thousand in FY 2024 .</li><li>Net loss: -$38,798 thousand in FY 2025 vs. -$82,183 thousand in FY 2024 .</li></ul><h4>Cash and Debt</h4><ul><li>Cash and Investments: Amarin Corporation plc (阿玛琳) reported $302.6 million in aggregate cash and investments as of December 31, 2025, an increase of $8.4 million from $294.2 million as of December 31, 2024, and a sequential increase of $16.0 million from $286.6 million as of September 30, 2025 .</li><li>Debt: The company remained debt-free as of December 31, 2025 .</li></ul><h4>Restructuring and Cost Savings</h4><ul><li>Amarin Corporation plc (阿玛琳) realized $31 million of the expected $70 million in cost savings from its restructuring initiatives .</li><li>The company incurred nearly all of the $37 - $40 million in restructuring costs, with $36.2 million incurred in full year 2025 and remaining charges expected in early 2026 .</li></ul><h3>Outlook / Guidance</h3><ul><li>Amarin Corporation plc (阿玛琳) expects to generate positive cash flow for the full year ahead (2026) . The company is well-positioned to deliver on its operational and strategic priorities in 2026 and continues to examine strategic actions to maximize future shareholder value and options regarding management of capital .</li></ul>

Amarin | 8-K: FY2025 Q4 Revenue Misses Estimate at USD 49.22 M